Analyst Ratings for Fate Therapeutics (FATE)
FATE Rating Summary
FATE Price Target Summary
- Highest: $7.00 (Wedbush)
- Lowest: $2.20 (BofA Securities)
- Average: $4.62
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$4.62 (+247.1%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 45%
Avg. $ Target:
$4.62 (+247.1%)
* Over Last 12-Mos
Rating Score: 4.4 / 10
Percentile Rank: 45%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/31/2025 | H.C. Wainwright | Debjit Chattopadhyay | Upgrade | Buy (Neutral) |
5.00 (N/A) |
1.29 (1.33) |
3.1% | Details |
| 10/27/2025 | Wedbush | Martin Fan | Upgrade | Outperform (Neutral) |
7.00 (5.00) |
1.65 (1.33) |
-19.39% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
